Seer (SEER) Non Operating Income (2020 - 2026)
Seer (SEER) recorded quarterly Non Operating Income of $429000.0 in Q1 2026, up 113.83% quarter-over-quarter from -$3.1 million in Q4 2025, and down 51.47% on a YoY basis from $884000.0 in Q1 2025.
Seer (SEER) Non Operating Income (2020 - 2026) Analysis & Trends
Seer's Non Operating Income history runs 7 years deep, the most recent figure standing at $429000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 51.47% year-over-year to $429000.0; the TTM figure through Mar 2026 stood at -$382000.0 (down 103.83% YoY), while the FY2025 annual figure was $73000.0, down 99.46% from the prior year.
- Non Operating Income was $429000.0 for Q1 2026 at Seer, up from -$3.1 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.8 million in Q3 2023 to a low of -$3.1 million in Q4 2025.
- Historically, Non Operating Income has averaged $2.1 million across 5 years, with a median of $1.8 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income soared 2390.0% in 2023, then slumped 268.17% in 2025.
- A 5-year view of Non Operating Income shows it stood at $2.4 million in 2022, then surged by 82.88% to $4.4 million in 2023, then plunged by 58.4% to $1.8 million in 2024, then plunged by 268.17% to -$3.1 million in 2025, then surged by 113.83% to $429000.0 in 2026.
- The last three Non Operating Income figures came in at $429000.0 (Q1 2026), -$3.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 429,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 429,000.00 |
| Dec 31, 2025 | -3.10 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 884,000.00 |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 4.25 Mn |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.43 Mn |
| Sep 30, 2023 | 4.76 Mn |
| Jun 30, 2023 | 4.51 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Dec 31, 2022 | 2.42 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 619,000.00 |
| Mar 31, 2022 | 140,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 55,000.00 |